Related Experiment Video
Updated: Jul 11, 2025
13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
2.7K
Reducing axillary surgery in breast cancer.
1Hospital Universitario Punta de Europa, Universidad de Cádiz, Spain.
Cirugia Espanola
|November 13, 2023
Summary
Surgical management of the positive axilla in breast cancer is evolving. Current trends and ongoing trials support avoiding axillary lymph node dissection solely for staging purposes.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Research
Background:
- The management of the positive axilla in breast cancer patients remains a controversial topic with varied surgical approaches.
- Historically, axillary lymph node dissection has been standard for staging, but its necessity is increasingly questioned.
Purpose of the Study:
- To review the recent evolution in the surgical management of the positive axilla in breast cancer.
- To highlight evidence supporting less aggressive surgical strategies.
- To discuss ongoing clinical trials investigating axillary management in breast cancer.
Main Methods:
- Literature review of recent studies and reports on axillary surgery in breast cancer.
- Analysis of current trends in surgical management.
- Discussion of ongoing clinical trials and their implications.
Main Results:
- Evidence suggests a trend towards reducing the aggressiveness of axillary surgery.
- Ongoing trials are investigating less invasive methods for axillary staging.
- The principle of avoiding axillary lymph node dissection for staging alone is gaining support.
Conclusions:
- The surgical management of the positive axilla in breast cancer is shifting towards less aggressive approaches.
- Ongoing research supports de-escalating axillary surgery when used solely for staging.
- Future breast cancer treatment may involve more conservative axillary management strategies.
